Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 448-455

  Chirmule, Narendra ^a   Truneh, Alemseged ^b   Haecker, Sarah Ehlen ^a   Tazelaar, John ^a   Gao, Guang Ping ^a   Raper, Steven E ^a   Hughes, Joseph V ^a   Wilson, James M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE ACTIVATION; GENE THERAPY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYSTIC FIBROSIS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAPERITONEAL; INTUBATION, INTRATRACHEAL; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; MICE, TRANSGENIC; TH1 CELLS; TH2 CELLS;

EID: 0033168141     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Yang, Y., F. Nunes, K. Berencsi, E. Furth, E. Gønczøl, and J. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
2. Crystal, R. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404.
3. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C.-S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42.
4. Welsh, M. J., A. E. Smith, J. Zabner, D. P. Rich, S. M. Graham, R. J. Gregory, B. M. Pratt, and R. A. Moscicki. 1994. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5:209.
5. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209.
6. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407.
7. Yang, Y., K. Greenough, and J. M. Wilson. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3:412.
8. Lei, D., M. Lehmann, J. E. Shellito, S. Nelson, A. Seigling, H.-D. Volk, and J. K. Kolls. 1996. Nondepleting anti-CD4 antibody treatment prolongs lung-directed E1-deleted adenovirus-mediated gene expression in rats. Hum. Gene Ther. 7:2273.
9. Oxenius, A., R. M. Zinkernagel, and H. Hengartner. 1998. Comparison of activation versus induction of unresponsiveness of virus-specific CD4 and CD8 T cells upon acute versus persistent virus infection. Immunity 9:449.
10. Rulifson, I. C., A. I. Sperling, P. E. Fields, F. W. Fitch, and J. A. Bluestone. 1997. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158:658.
11. Janeway, C. 1991. The co-receptor function of CD4. Semin. Immunol. 3:153.
12. Young, A. C. M., S. G. Nathenson, and J. C. Sacchettini. 1995. A structural view of CD4 and CD8. FASEB J. 9:26.
13. Killeen, N., S. Sawada, and D. R. Littman. 1993. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12:1547.
14. Cammarota, G., A. Scheirle, B. Takacs, D. M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 356:799.
15. Doyle, C., and J. L. Strominger. 1987. Interaction between CD4 and class II MHC moleculars mediates cell adhesion. Nature 330:256.
16. Clayton, L., K. M. Sieh, D. A. Pious, and E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 319:548.
17. von Hoegen, P., M. C. Miceli, B. Tourvieille, M. Cshilhamn, and J. R. Parnes. 1989. Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II restricted T cell hybridoma. J. Exp. Med. 170:1879.
18. lck in antigen-specific signal transduction in T cells. Cell 64: 511.
19. Goldman, M. J., L. Litzky, J. F. Engelhardt, and J. M. Wilson. 1995. Transfer of the CFTR gene to the lung of nonhuman primates with E1 deleted, E2a defective recombinant adenoviruses: a preclinical toxicology study. Hum. Gene Ther. 6:839.
20. Engelhardt, J., R. Simon, Y. Yang, M. Zepeda, S. Pendleton, B. Doranz, M. Grossman, and J. Wilson. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:759.
21. Chirmule, N., J. V. Hughes, G. P. Gao, S. E. Raper, and J. M. Wilson. 1998. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 72:6138.
22. Fowell, D. J., J. Magram, C. W. Turck, N. Killeen, and R. M. Locksley. 1997. Impaired Th2 subset development in the absence of CD4. Immunity 6:559.
23. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
24. Chirmule, N., and S. Pahwa. 1996. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60:386.
25. lck association. Nature 364:729.
26. Brown, D. R., N. Moskowitz, N. Killeen, and S. L. Reiner. 1997. A role of CD4 in peripheral T cell differentiation. J. Exp. Med. 186:101.
27. Rep, M. H., B. W. van Oosten, M. T. Roos, H. J. Ader, C. H. Polman, and R. A. van Lier. 1997. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-γ secreting Th1 cells in humans. J. Clin. Invest. 95:2225.
28. Yang, Y., H. Ertl, and J. Wilson. 1994. MHC class 1 restricted cytotoxic T lymphocytes to viral antigens destroy hepalocytes in mice infected with E1 deleted recombinant adenoviruses. Immunity 1:433.
29. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004.